There is no pinned content in this Editor's Picks module.
Click here to learn more about content pinning.
KGaA ( MKGAF ) recently announced that it has entered into a global agreement with Threshold Pharmaceuticals, Inc. TH-302 is currently being evaluated in late-stage studies, initiated in September 2011, in patients with soft tissue sarcoma. Also, the...
FILE - In this Feb. 21, 2011 file picture CEO of Merck KGaA, Karl-Ludwig Kley, speaks at a balance press conference in Darmstadt, Germany. Pharmaceutical and biotech equipment company Merck said Wednesday Oct. 26, 2011 its net income rose 7.5 percent... View Photo »
We appreciate the efforts made by the Merck KGaA team members in significantly advancing this program.
KGaA (MKGAF) recently announced that it has entered into a global agreement with Threshold Pharmaceuticals, Inc. (THLD), for the development and commercialization of the latter’s hypoxia-targeted candidate, TH-302. TH-302 is currently being evaluated in...
If TH-302 continues to appear effective -- with minimal side effects, then Threshold will receive up to $280 million in additional milestone payments in 2013 and 2014. If the drug finally gets approved, perhaps as soon as the fourth quarter of 2013 but...
BioMarin; Aldurazyme® (laronidase) for mucopolysaccharidosis I (MPS I), a product which BioMarin developed through a 50/50 joint venture with Genzyme Corporation; Kuvan® (sapropterin dihydrochloride) Tablets, for phenylketonuria (PKU), developed in...
The transfer of the vanity URL Facebook.com/Merck from Merck KGaA to Merck & Co was due to an administrative error. We apologize for any inconvenience this may have caused.
Pennystocksinsiders.com thinks that it is a clever way to check if insiders like CEOs, CFOs, and Directors in AA are starting to buy more company shares. See insider trade report for AA here. Threshold Pharmaceuticals, Inc. (NASDAQ: THLD): Threshold...
KGaA agreed to pay Threshold Pharmaceuticals Inc. as much as $525 million for the right to jointly develop and sell a drug for cancer, sending the California company’s stock up 67 percent in premarket trading. The German drugmaker will pay $25 million...
Merck KGaA is a German-based chemical and pharmaceutical company. Merck (also referred to as “German Merck” or “Merck Darmstadt”) was founded in Darmstadt, Germany, in 1668 and is one of the oldest still-operating chemical/pharmaceutical companies in the world. The company was privately owned until going public in 1995. However, the Merck family... Full Article
We appreciate the efforts made by the Merck KGaA team members in significantly advancing this program.
The transfer of the vanity URL Facebook.com/Merck from Merck KGaA to Merck & Co was due to an administrative error. We apologize for any inconvenience this may have caused.
With its Candurin® range, Merck KGaA has overcome challenges associated with pearlescent pigments, including dust in the food manufacturing center, safety and labelling data, technical support for application development and stability
